Combined Effect of Panchagavya Ghrita and Roudrarasa in the Management of Oral Squamous Cell Carinoma (OSCC) as adjuvant Therapy

A Clinical Comaparative Study On Role of Panchagavya Ghrta and Roudra rasa as a adjuvant therapy in the management of Oral Squamous Cell Carcinoma OSCC - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067548

Enrollment

Registered

2024-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age of 30 to70 years of either sex Fit with all subjective and objective criteria Diagnosed and Histopathologically proved postSurgical or Chemotherapy and Radiotherapy cases of OSCC Radiation volume between 100 cm2 to 170cm2

Exclusion criteria

Exclusion criteria: Metastatic origin HIV Active Hepatitis Haematemesis etc

Design outcomes

Primary

Measure	Time frame
The study will be carried out on 30 sample size to know the efficacy of Panchagavya ghrta and Roudra rasa after CT and RT of Oral Squamous cell Carcinoma as an comparative with only CT RT as control group for the study period of one and half yearTimepoint: 45 days medicine will be given to patient and assessment will be done before and after the therapy for 45 days and follow up for 3 months and the total study period will be for one and half years	—

Measure

Time frame

The study will be carried out on 30 sample size to know the efficacy of Panchagavya ghrta and Roudra rasa after CT and RT of Oral Squamous cell Carcinoma as an comparative with only CT RT as control group for the study period of one and half yearTimepoint: 45 days medicine will be given to patient and assessment will be done before and after the therapy for 45 days and follow up for 3 months and the total study period will be for one and half years

—

Secondary

Measure	Time frame
The comparative study helps in giving a quality of life & reducing a disease as well as post CT RT complications with cost effective management of Oral Squamous Cell CarcinomaTimepoint: treatment will be given for 45 days & follow up will be done for 3 months	—

Countries

India

Contacts

Public ContactDr Shrinivasraddi Venkaraddiyavar

Sanjeevini Ayurveda Medical College and Hospital Hubballi

shrinivas.reddy620@gmail.com9742902770

Outcome results